BancFirst Corporation (BANF)
Official siteFINANCIAL SERVICES • BANKS - REGIONAL • NASDAQ
Market Cap: $3.99B
Last updated: Nov 17, 2026 at 11:05 AM ET
BancFirst Corporation (BANF) Stock Forecast
Analysts expect BancFirst (BANF) to earn $7.69 per share in the fiscal year ending Dec 31, 2026, on revenue of $747.40M. Of 3 analysts, 0 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 3 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 3 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 6.4% and revenue estimates rise 7.0%.
- Fiscal year ending Dec 31, 2026
- $7.69
- EPS consensus, revenue $747.40M
- Fiscal year ending Dec 31, 2027
- $8.18
- EPS consensus, revenue $799.70M
- Next report
- Jan 20, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $7.69 | $7.58 to $7.77 | 3 | $747.40M | $747.00M to $747.80M | 2 |
| Dec 31, 2027 | $8.18 | $8.01 to $8.27 | 3 | $799.70M | $797.70M to $801.70M | 2 |
Quarterly Estimates
The EPS consensus rises from $2.02 for the quarter ending Dec 31, 2026 to $2.04 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.02 | $1.90 to $2.11 | 5 | $198.13M | $190.05M to $204.30M | 4 |
| Mar 31, 2027 | $2.04 | $2.03 to $2.04 | 2 | $196.35M | $195.00M to $197.69M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 7 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 3 | 0 |
| Quarter ending Mar 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 0.3% from $7.67.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $7.69 | $7.72 | $7.67 | $7.67 | $7.67 | +0.3% |
| Fiscal year ending Dec 31, 2027 | $8.18 | $8.04 | $7.85 | $7.85 | $7.64 | +7.0% |
| Quarter ending Mar 31, 2027 | $2.04 | $2.05 | $1.96 | $1.96 | $1.97 | +3.3% |
Frequently Asked Questions About BANF
What is the BANF stock forecast?
Consensus analyst estimates put BancFirst's EPS at $7.69 for the fiscal year ending Dec 31, 2026, on revenue of $747.40M. The consensus rating from 3 analysts is Hold.
How do analysts rate BANF stock?
Of 3 analysts covering BancFirst, 0 rate it Strong Buy, 0 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from BANF next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $7.69, with estimates from $7.58 to $7.77 from 3 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $8.18, with estimates from $8.01 to $8.27 from 3 analysts.
What revenue do analysts expect from BancFirst next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $747.40M, with estimates from $747.00M to $747.80M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $799.70M, with estimates from $797.70M to $801.70M.
How many analysts cover BANF?
3 analysts rate BancFirst stock, and 3 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
BANF pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors